180 related articles for article (PubMed ID: 11655206)
1. The commercialization of clinical genetics: an analysis of interrelations between academic centers and for-profit clinical genetics diagnostics companies.
Natowicz MR; Ard C
J Genet Couns; 1997 Sep; 6(3):337-55. PubMed ID: 11655206
[No Abstract] [Full Text] [Related]
2. Breaking ranks, lab offers test to assess risk of breast cancer.
Kolata G
N Y Times Web; 1996 Apr; ():A1, A15. PubMed ID: 11647501
[No Abstract] [Full Text] [Related]
3. A national dialogue on genetics and minority issues.
Mittman IS; Secundy MG
Community Genet; 1998; 1(3):190-200. PubMed ID: 11657309
[No Abstract] [Full Text] [Related]
4. Commerce and genetic diagnostics.
Silverman PH
Hastings Cent Rep; 1995; 25(3 Suppl):S15-8. PubMed ID: 11654185
[TBL] [Abstract][Full Text] [Related]
5. Eugenics and the new genetics in Britain: examining contemporary professionals' accounts.
Kerr A; Cunningham-Burley S; Amos A
Sci Technol Human Values; 1998; 23(2):175-98. PubMed ID: 11656684
[No Abstract] [Full Text] [Related]
6. University-industry relationships in genetic research: potential opportunities and pitfalls.
Walsh ME; Graber GC; Wolfe AK
Account Res; 1997; 5(4):265-82. PubMed ID: 11656993
[No Abstract] [Full Text] [Related]
7. Genetic testing outside research acceptable, says Cancer Society.
Nature; 1996 May; 381(6579):184. PubMed ID: 11644781
[No Abstract] [Full Text] [Related]
8. The duty to recontact: attitudes of genetics service providers.
Fitzpatrick J; Hahn C; Costa T; Huggins M
Am J Hum Genet; 1997 Oct; 61(4):A57. PubMed ID: 11644972
[No Abstract] [Full Text] [Related]
9. Screening policy for cystic fibrosis: the role of evidence.
Wilfond BS
Hastings Cent Rep; 1995; 25(3 Suppl):S21-3. PubMed ID: 11654188
[TBL] [Abstract][Full Text] [Related]
10. Non-starters and no brainers: an outside perspective.
David EE
Account Res; 1997; 5(4):255-63. PubMed ID: 11656992
[No Abstract] [Full Text] [Related]
11. The American Society of Clinical Oncology position on genetic testing: implications for health care providers: workshop no. 4.
Garber JE; Offit K; Olopade OI; Fink D; Barbasch A; Barr P; Gleeson RK; Le Stage B
Cancer; 1997 Aug; 80(3 Suppl):632-4. PubMed ID: 11657063
[No Abstract] [Full Text] [Related]
12. Refusal of employment or insurance.
Fletcher JC; Wertz DC
Am J Hum Genet; 1997 Oct; 61(4):A56. PubMed ID: 11644971
[No Abstract] [Full Text] [Related]
13. Academic-corporate ties in biotechnology: a quantitative study.
Krimsky S; Ennis JG; Weissman R
Sci Technol Human Values; 1991; 16(3):275-87. PubMed ID: 11652031
[No Abstract] [Full Text] [Related]
14. Coming into being: law, ethics, and the practice of prenatal genetic screening.
Malinowski MJ
Hastings Law J; 1994 Aug; 45(6):1435-526. PubMed ID: 11653304
[No Abstract] [Full Text] [Related]
15. Indiana clergy: a survey of their human genetics/bioethics educational needs.
Mertens TR; Hendrix JR; Mendenhall GL
J Pastoral Care; 1986 Mar; 40(1):43-53. PubMed ID: 11645584
[No Abstract] [Full Text] [Related]
16. Mail order gene testing.
Bull S
Bull Med Ethics; 1996 Feb; No. 115():20-1. PubMed ID: 11660246
[No Abstract] [Full Text] [Related]
17. The commercialization of human genetics: profits and problems.
Caulfield T
Mol Med Today; 1998 Apr; 4(4):148-50. PubMed ID: 9572055
[TBL] [Abstract][Full Text] [Related]
18. Homo economicus: commercialization of body tissue in the age of biotechnology.
Nelkin D; Andrews L
Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768
[TBL] [Abstract][Full Text] [Related]
19. Gene tests offered to UK public.
Sharp D
Lancet; 1997 Oct; 350(9083):1013. PubMed ID: 11655214
[No Abstract] [Full Text] [Related]
20. Cancer genetics program within an HMO: a model of confidential service.
Mecsas-Faxon S; Tishler S; Pauker SP
Am J Hum Genet; 1997 Oct; 61(4):A224. PubMed ID: 11644967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
